Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia

The genetic architecture of cancer has been delineated through advances in high‐throughput next‐generation sequencing, where the sequential acquisition of recurrent driver mutations initially targeted towards normal cells ultimately leads to malignant transformation. Myelodysplastic syndromes (MDS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Woll, Petter S., Yoshizato, Tetsuichi, Hellström‐Lindberg, Eva, Fioretos, Thoas, Ebert, Benjamin L., Jacobsen, Sten Eirik W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Symposium: Precision Medicine in Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544124/
https://www.ncbi.nlm.nih.gov/pubmed/35822488
http://dx.doi.org/10.1111/joim.13535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544124/
https://www.ncbi.nlm.nih.gov/pubmed/35822488
http://dx.doi.org/10.1111/joim.13535

Ejemplares similares